Skip to main content
ConductScienceScienceDex

Humam Kadara

NIH Rank #4541
Unclaimed recordClaim profile
  • Program Leader
  • R01 Holder
  • Translational
  • Early Career

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 10539538Search this ID in NIH RePORTER
ScienceDex PI coverage
FY2024 through FY2026Career claims are limited to the years shown.

FY2026 award categories

  • Pathology
  • Biochemistry

NIH Funding · FY2026

Linked Award Amount
$1.6M
Full award amounts, FY2026
Award Records
3
Records listing this PI
Award-Linked Rank
#4,541
By linked amount among FY2026 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Humam Kadara. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2026 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2026 award records by amount

NIH award records listing Humam Kadara as a PI. Multi-PI records show the full award amount for context.

  • 1R01CA301423-01A1R01
    Elucidating roles of the CD24 ligand in early lung cancer development, immune evasion and response to KRAS-targeted therapy
    UT MD Anderson Cancer Center
    $669.5K
    award amount
  • 5R01CA272863-05R01
    Elucidating the evolution of Krt8+ alveolar cells to Kras-mutant lung preneoplasia and cancer
    UT MD Anderson Cancer Center
    $544.5K
    award amount
  • 5U01CA264583-05U01
    Spatial and temporal tumor-immune co-evolution and interactions that model lung adenocarcinoma development
    UT MD Anderson Cancer Center
    $408.2K
    award amount

Award organization

Organizations that administered FY2026 awards listing Humam Kadara as a PI.

FY2026 award administered by UT MD Anderson Cancer Center (TX).

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    UT MD Anderson Cancer Center
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    $2M Cumulative Funding
  5. 2024
    Entered Top 50% Nationally
    Ranked #4490
  6. 2024
    Entered Top 25% Nationally
    Ranked #4490
  7. 2025
    R01 Grant Holder
  8. 2025
    Program/Center Grant Leader
  9. 2026
    $5M Cumulative Funding

Shared-award investigators

Other investigators listed on at least one of the same NIH award records as Humam Kadara.

Seyed Javad Mirhassani Moghaddam
UT MD Anderson Cancer Center
5
shared awards
Linghua Wang
UT MD Anderson Cancer Center
3
shared awards
Tina Cascone
UT MD Anderson Cancer Center
2
shared awards
Ferdinandos Skoulidis
UT MD Anderson Cancer Center
1
shared award

Explore further

Find collaborators for Humam Kadara

Search NIH-funded principal investigators by topic, department, or activity.

Open Find Collaborators →

Benchmark grant budgets

Compare median NIH grant budgets across departments, mechanisms, and years.

Open Grant Budget Benchmark →